Figure 1: Randomization Scheme for Cohort A |
Figure 2: Death and Adverse Events at 30 Days (ITT), TAVI vs. sAVRa |
Figure 3: Death and Adverse Events at 1 Year (ITT), TAVI vs. sAVRa |
Figure 4: Death and Adverse Events at 30 Days (ITT), TF TAVI vs. sAVRa |
Figure 5: Death and Adverse Events at 1 Year (ITT), TF TAVI vs. sAVRa |
Figure 6: Death and Adverse Events at 30 Days (ITT), TA TAVI vs. sAVRa |
Figure 7: Death and Adverse Events at 1 Year (ITT), TA TAVI vs. sAVRa |
Figure 8: Mortality Rates at 30 Days |
Figure 9: Mortality Rates at 1 Year |
Figure 10: Rate of Stroke/TIA at 30 Days |
Figure 11: Rate of Stroke/TIA at 1 Year |
Figure 12: Rates of Complications at 30 Days |
Figure 13: Rates of Complications at 1 Year |
Figure 14: 30-Day Postoperative Decision Tree |
Figure 15: Long-Term Markov Model |
Figure A1: Death and Adverse Events at 30 Days, TAVI vs. sAVRa |
Figure A2: Death and Adverse Events at 1 Year, TAVI vs. sAVRa |
Figure A3: Death and Adverse Events at 30 Days, TF TAVI vs. sAVRa |
Figure A4: Death and Adverse Events at 1 Year, TF TAVI vs. sAVRa |
Figure A5: Death and Adverse Events at 30 Days, TA TAVI vs. sAVRa |
Figure A6: Death and Adverse Events at 1 Year, TA TAVI vs. sAVRa |